OrganaBio are hiring!
A national leader in pediatric oncology research and treatment, Dr Laetsch will also lead CHOP's Developmental Therapeutics Program
Breakthrough automation technology for cell therapy products to enable scale-up of production volumes and reduction of...
Non-dilutive debt; no amortisation for seven months; maturity of 21 Months
Phase I/II study in patients with solid tumours expected to commence in Q3 2020 at leading sites in the United States
Tessa Therapeutics announces results from two independent phase I/II trials of autologous CD30 CAR-T cell therapy in patients...
Dr Davidson, a lipidology expert, joins the board at Caladrius
Kite Becomes the First Company with Multiple Approved CAR T Therapies
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investment
Adva Biotechnology are hiring!
Leading-edge, comprehensive electronic format master files for IL-2, IL-7, IL-15, and IL-21 provide transparency and regulatory support for cell...
An update on Phacilitate's rebrand activities
Details of the agreement between Moderna and Catalent
Akron Biotech are hiring!